BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19255117)

  • 1. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma.
    May M; Brookman-Amissah S; Pflanz S; Roigas J; Hoschke B; Kendel F
    Br J Radiol; 2009 Aug; 82(981):724-31. PubMed ID: 19255117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal artery embolization prior to nephrectomy for locally advanced renal cell carcinoma.
    Zargar H; Addison B; McCall J; Bartlett A; Buckley B; Rice M
    ANZ J Surg; 2014; 84(7-8):564-7. PubMed ID: 24548680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal artery embolization: clinical indications and experience from over 100 cases.
    Schwartz MJ; Smith EB; Trost DW; Vaughan ED
    BJU Int; 2007 Apr; 99(4):881-6. PubMed ID: 17166242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma.
    Zielinski H; Szmigielski S; Petrovich Z
    Am J Clin Oncol; 2000 Feb; 23(1):6-12. PubMed ID: 10683065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
    Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ;
    BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival advantage with partial nephrectomy: a bias of observational data?
    Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
    Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma.
    Lin PH; Terramani TT; Bush RL; Keane TE; Moore RG; Lumsden AB
    J Vasc Surg; 2003 Sep; 38(3):446-50. PubMed ID: 12947251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative renal tumor embolization. A useful procedure?
    Fischedick AR; Peters PE; Kleinhans G; Pfeifer E
    Acta Radiol; 1987; 28(3):303-6. PubMed ID: 2958037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal artery embolisation prior to radical nephrectomy for renal cell carcinoma: when, how and why?
    Loffroy R; Rao P; Ota S; Geschwind JF
    Br J Radiol; 2010 Jul; 83(991):630; author reply 631-2. PubMed ID: 20603414
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
    Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
    BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.